UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:July 02,
Bellerophon Therapeutics (NASDAQ:BLPH)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Bellerophon Therapeutics Charts.
Bellerophon Therapeutics (NASDAQ:BLPH)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Bellerophon Therapeutics Charts.

Bellerophon Therapeutics, Inc. News

Form 8-K - Current report
Wednesday 31 January 2024 (3 months ago) • Edgar (US Regulatory)
Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individuals
Saturday 27 January 2024 (3 months ago) • Edgar (US Regulatory)
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Saturday 27 January 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 23 January 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 11 January 2024 (4 months ago) • Edgar (US Regulatory)
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)
Form PRE 14A - Other preliminary proxy statements
Saturday 28 October 2023 (6 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 October 2023 (7 months ago) • Edgar (US Regulatory)
Form RW - Registration Withdrawal Request
Tuesday 17 October 2023 (7 months ago) • Edgar (US Regulatory)
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Tuesday 17 October 2023 (7 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Saturday 14 October 2023 (7 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Friday 13 October 2023 (7 months ago) • Edgar (US Regulatory)

More Bellerophon Therapeutics, Inc. News Articles